DyeVert is intended to reduce the amount of contrast media given during coronary and peripheral angiographies.
 
Status In progress
Process MT
ID number 550

Provisional Schedule

Committee meeting: MTAC 2 23 July 2021
Resolution 23 August 2021
Expected publication 04 October 2021

Project Team

Project lead Charlotte Pelekanou

Email enquiries

Stakeholders

External assessment group KiTEC
Manufacturers Osprey Medical
Others Association of British Healthcare Industries (ABHI)
  Association of Healthcare Technology Providers for Imaging, Radiotherapy and Care (AXrEM)
  Boston Scientific
  Department of Health and Social Care
  Devices for Dignity
  Greater Manchester Health & Social Care Partnership
  Healthcare Improvement Scotland
  HealthTech Alliance
  Johnson & Johnson Medical Ltd
  Medical Technology Group
  Medicines and Healthcare Products Regulatory Agency
  University of Manchester Wounds Research Group
  NHS England
  NHS England
  NHS England
  NHS England
  NHS England
  The British In Vitro Diagnostics Association (BIVDA)
  NHS Digital

Timeline

Key events during the development of the guidance:

Date Update
14 May 2021 - 11 June 2021 Draft guidance
23 April 2021 Committee meeting: MTAC 1
18 December 2020 Scope published
04 November 2020 Stakeholder registration opens

For further information on how we develop guidance, please see our page about NICE medical technologies guidance